期刊文献+

To explore the pathogenesis of anterior resection syndrome by magnetic resonance imaging rectal defecography

在线阅读 下载PDF
导出
摘要 BACKGROUND Over 90%of rectal cancer patients develop low anterior resection syndrome(LARS)after sphincter-preserving resection.The current globally recognized evaluation method has many drawbacks and its subjectivity is too strong,which hinders the research and treatment of LARS.AIM To evaluate the anorectal function after colorectal cancer surgery by quantifying the index of magnetic resonance imaging(MRI)defecography,and pathogenesis of LARS.METHODS We evaluated 34 patients using the standard LARS score,and a new LARS evaluation index was established using the dynamic images of MRI defecography to verify the LARS score.RESULTS In the LARS score model,there were 10(29.41%)mild and 24(70.58%)severe cases of LARS.The comparison of defecation rate between the two groups was 29.36±14.17%versus 46.83±18.62%(P=0.004);and MRI-rectal compliance(MRI-RC)score was 3.63±1.96 versus 7.0±3.21(P=0.001).Severe and mild LARS had significant differences using the two evaluation methods.There was a significant negative correlation between LARS and MRI-RC score(P<0.001),and they had a negative correlation with defecation rate(P=0.028).CONCLUSION MRI defecography and standard LARS score can both be used as an evaluation index to study the pathogenesis of LARS.
出处 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第2期529-538,共10页 世界胃肠外科杂志(英文版)(电子版)
  • 相关文献

参考文献2

二级参考文献35

  • 1万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1375
  • 2[1]Simmonds P,Holmes EC,Cha TA,Chan SW,McOmish F,Irvine B,Beall E,Yap PL,Kolberg J,Urdea MS.Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.J Gen Virol 1993; 74 (Pt 11):2391-2399
  • 3[2]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52
  • 4[3]Hoofnagle JH.Course and outcome of hepatitis C.Hepatology 2002; 36:S21-S29
  • 5[4]Pozzato G,Kaneko S,Moretti M,Croce LS,Franzin F,Unoura M,Bercich L,Tiribelli C,Crovatto M,Santini G.Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease.J Med Virol 1994; 43:291-296
  • 6[5]Hopf U,Berg T,Konig V,Kuther S,Heuft HG,Lobeck H.Treatment of chronic hepatitis C with interferon alpha:longterm follow-up and prognostic relevance of HCV genotypes.J Hepatol 1996; 24:S67-S73
  • 7[6]Neville JA,Prescott LE,Bhattacherjee V,Adams N,Pike I,Rodgers B,El-Zayadi A,Hamid S,Dusheiko GM,Saeed AA,Haydon GH,Simmonds P.Antigenic variation of core,NS3,and NS5 proteins among genotypes of hepatitis C virus.J Clin Microbiol 1997; 35:3062-3070
  • 8[7]Lindsay KL,Trepo C,Heintges T,Shiffman ML,Gordon SC,Hoefs JC,Schiff ER,Goodman ZD,Laughlin M,Yao R,Albrecht JK.A randomized,double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.Hepatology 2001; 34:395-403
  • 9[8]Manns MP,McHutchison JG,Gordon SC,Rustgi VK,Shiffman M,Reindollar R,Goodman ZD,Koury K,Ling M,Albrecht JK.Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C:a randomised trial.Lancet 2001; 358:958-965
  • 10[9]Wong JB,Davis GL,McHutchison JG,Manns MP,Albrecht JK.Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C.Am J Gastroenterol 2003; 98:2354-2362

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部